The new PCR-based FluoroType MTBDR 2.0 assay identifies tuberculosis pathogens, as well as several important antibiotic resistance characteristics in only three hours.
The FluoroType MTBDR 2.0 assay can detect more than 60 mutations in the TB genes, leading up to 522 resistance patterns with relevant information to guide therapy.
Microbiologa Clnica at the Universidad Autnoma de Madrid stated: We will implement the new high-resolution FluoroType MTBDR 2.0 test together with the newly developed, high-performance optical FluoroCycler XT to improve our ability to diagnose acute TB with greater specificity and as quickly as possible.
The first Liquid Array assay will be the Fluorotype
MTBDR 2.0 for detecting the M.
David Hain, Managing Director of the renamed Bruker-Hain Diagnostics MDx business, said: We expect the launch of our new Fluorotype MTBDR 2.0 Liquid Array tuberculosis assay in selected markets that accept the CE-IVD mark already in the fourth quarter of 2018.
Warren at the DST-NRF Centre of Excellence for Biomedical Tuberculosis Research and SAMRC Centre for Tuberculosis Research at Stellenbosch University, South Africa, stated: We have already been successfully using the Hain GenoType portfolio and Fluorotype MTBDR assay for mycobacteria analysis.
Voluntary ex ante transparency notice: Purchase of fluorotype
mtbdr to the international reference laboratory of mycobacteriology (irlm) statens serum institut.